{
  "id": 13152636,
  "title": "STAT+: Life Biosciences share glaucoma study updates for its cellular reprogramming drug",
  "url": "https://urgent.news/2026/10/09/stat-life-biosciences-share-glaucoma-study-updates-for-its-cellular",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-09T15:41:39.000Z",
  "source": {
    "name": "STAT News",
    "slug": "stat-news",
    "url": "https://www.statnews.com/2026/10/09/biotech-news-life-biosciences-share-glaucoma-cellular-reprogramming-drug-update/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Life Biosciences said yesterday that three glaucoma patients have now received a single injection of its experimental cellular reprogramming drug, with no serious adverse events.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}